3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Ovarian Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma
1
Fallopian Tube Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Adenoviridae Infections
1
Interventions
pembrolizumab
1
liposomal doxorubicin
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Adenoviridae Infections
×
1-dodecylpyridoxal
×
Clear all
NCT05271318
2026-05-05
PROTA
TILT Biotherapeutics Ltd.
Phase 1/2
Active not recruiting
29 enrolled